Scientific Impact

Here is a summary of some recent major scientific discoveries facilitated the Cancer Biostatistics (CB) Shared Resource.

Scientific Finding:

Sulindac plus erlotinib reduces duodenal polyps in FAP patients

Services Used:

  • Clinical trial design in P01 application
  • Interim and final analysis
  • Manuscript preparation and revision

Citation:

  • JAMA 2016, 315 (12): 1266
  • JAMA Oncol 2018 (Epub)

Scientific Finding:

Telecare increased colonoscopy uptake regardless of cost barriers

Services Used:

  • Trial design in R01 application
  • Analysis
  • Manuscript preparation

Citation:

  • Cancer Epidemiol Biomarkers Prev 2015, 24(9): 1311

Scientific Finding:

Association between socioeconomic factors and breast cancer survival differs by race

Services Used:

  • Statistical analysis
  • Manuscript preparation

Citation:

  • PLoS One 2017, 12(12) e0187018

Scientific Finding:

Breast conservation surgery associated with superior cancer-specific survival to mastectomy or mastectomy plus radiation

Services Used:

  • Statistical analysis
  • Manuscript preparation

Citation:

  • JAMA Surgery 2014,149 (3): 267

Scientific Finding:

Response to 7 days of tamoxifen is similar to longer courses in breast cancer patients

Services Used:

  • Clinical trial design
  • Analysis
  • Manuscript preparation

Citation:

  • Breast 2017, 31: 219

Scientific Finding:

Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework.

Services Used:

  • Model development
  • Confirmation

Citation:

  • Genet. Med. 2018. Epub

Scientific Finding:

Describing the Spectrum of Patient Reported Outcomes after Radical Prostatectomy: Providing Information to Improve Patient Counseling and Shared Decision Making

Services Used:

  • Nonparametric Bayesian mixed model for distribution of functional outcomes post-prostatectomy

Citation:

  • Journal of Urology. 2018. Epub.

Scientific Finding:

Treatment of metastatic renal cell carcinoma in older patients: A network meta-analysis

Services Used:

  • Joint network meta-analysis of mRCC therapies for older patients

Citation:

  • Journal of Geriatric Oncology. 2018. Epub.

Scientific Finding:

Optimal First-Line Treatment of Metastatic Renal-Cell Carcinoma: A Network Meta-Analysis

Services Used:

  • Joint network meta-analysis of first-line mRCC therapies

Citation:

  • Kidney Cancer. 2018. 2(2):115-121.

Contact Us

Cancer Biostatistics Co-Directors
Kenneth M. Boucher, PhD
ken.boucher@hci.utah.edu
801-585-9544

Benjamin Haaland, PhD
Ben.Haaland@hci.utah.edu
801-213-3485

Request Collaboration

Governance

HCI Senior Director Oversight
Tracy Onega, PhD, MS

Faculty Advisory Committee Chair
David Gaffney, MD, PhD

Faculty Advisory Committee Members
Anne Kirchhoff, PhD
David Lum, PhD
Benjamin Maughan, MD
Benjamin Spike, PhD
Katherine Varley, PhD